NCT01467115 Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01466244 Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 Status COMPLETED Phase N/A
NCT01462474 Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE1
NCT01461772 Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer Status TERMINATED Phase PHASE3
NCT01461759 Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT01461746 Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT01461057 A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01460537 Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01459614 Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01454102 Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) Status COMPLETED Phase PHASE1
NCT01454089 A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT01450761 Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone Status COMPLETED Phase PHASE3
NCT01450696 A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer Status TERMINATED Phase PHASE3
NCT01445405 Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01445392 SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma Status TERMINATED Phase PHASE1
NCT01443078 Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) Status COMPLETED Phase PHASE2
NCT01437449 Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Status COMPLETED Phase PHASE2
NCT01417390 Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE2
NCT01414608 Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Status COMPLETED Phase PHASE3